{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T08:18:13Z","timestamp":1772612293033,"version":"3.50.1"},"reference-count":37,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"unspecified","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2023,9,4]]},"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:p>We report the case of nephrotic syndrome after COVID-19 vaccination. The patient was a man in his 30s with no comorbidities other than atopic dermatitis. Over the course of 2\u2009weeks after the first COVID-19 vaccination, systemic oedema gradually appeared. He was referred to the nephrology department for investigation of the systemic oedema. On admission, he presented with pitting oedema in his lower extremities. Initial examinations revealed massive urinary protein and decreased serum albumin, at 13.9\u2009g\/g Cr and 1.5\u2009g\/dL, respectively. Renal biopsy was performed, and minimal change disease was diagnosed. Prednisolone 60\u2009mg\/day was promptly started on the 5th day of hospitalisation, and complete remission was achieved on the 12th day. Prednisolone was once tapered off in 1.5 years successfully though minimal change disease was relapsed in 1\u2009month after the steroid withdrawal.<\/jats:p>","DOI":"10.1136\/bcr-2023-255144","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T12:20:13Z","timestamp":1694780413000},"page":"e255144","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["New-onset minimal change disease following the Moderna COVID-19 vaccine"],"prefix":"10.1136","volume":"16","author":[{"given":"Nobuteru","family":"Kobayashi","sequence":"first","affiliation":[{"name":"Nephrology, Yokohama City Minato Red Cross Hospital, Yokohama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Fujisawa","sequence":"additional","affiliation":[{"name":"Nephrology, Yokohama City Minato Red Cross Hospital, Yokohama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiro","family":"Kumagai","sequence":"additional","affiliation":[{"name":"Pathology, Yokohama City Minato Red Cross Hospital, Yokohama, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madoka","family":"Tanabe","sequence":"additional","affiliation":[{"name":"Nephrology, Yokohama City Minato Red Cross Hospital, Yokohama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,9,15]]},"reference":[{"key":"2025082700475145000_16.9.e255144.1","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2020.4555"},{"key":"2025082700475145000_16.9.e255144.2","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1001\/jama.2021.5374","article-title":"Reactogenicity following receipt of mRNA-based COVID-19 vaccines","volume":"325","author":"Chapin-Bardales","year":"2021","journal-title":"JAMA"},{"key":"2025082700475145000_16.9.e255144.3","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7008e3"},{"key":"2025082700475145000_16.9.e255144.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035389"},{"key":"2025082700475145000_16.9.e255144.5","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2021.03.010"},{"key":"2025082700475145000_16.9.e255144.6","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1053\/j.ajkd.2021.05.003","article-title":"An additional case of minimal change disease following the Pfizer-biontech COVID-19 vaccine","volume":"78","author":"Maas","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"2025082700475145000_16.9.e255144.7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.kint.2021.04.035","article-title":"Minimal change disease and acute kidney injury following the Pfizer-biontech COVID-19 vaccine","volume":"100","author":"D\u2019Agati","year":"2021","journal-title":"Kidney Int"},{"key":"2025082700475145000_16.9.e255144.8","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.kint.2021.05.007","article-title":"Minimal change disease following the moderna mRNA-1273 SARS-Cov-2 vaccine","volume":"100","author":"Holzworth","year":"2021","journal-title":"Kidney Int"},{"key":"2025082700475145000_16.9.e255144.9","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.kint.2021.06.004","article-title":"Post-vaccinal minimal change disease","volume":"100","author":"Weijers","year":"2021","journal-title":"Kidney Int"},{"key":"2025082700475145000_16.9.e255144.10","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2021.36.e218","article-title":"New-onset nephrotic syndrome after janssen COVID-19 vaccination: a case report and literature review","volume":"36","author":"Lim","year":"2021","journal-title":"J Korean Med Sci"},{"key":"2025082700475145000_16.9.e255144.11","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1016\/j.ekir.2021.07.017","article-title":"Report of three cases of minimal change disease following the second dose of mRNA SARS-CoV-2 COVID-19 vaccine","volume":"6","author":"Salem","year":"2021","journal-title":"Kidney Int Rep"},{"key":"2025082700475145000_16.9.e255144.12","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1186\/s12882-021-02583-9","article-title":"Minimal change disease following the moderna COVID-19 vaccine: first case report","volume":"22","author":"Thappy","year":"2021","journal-title":"BMC Nephrol"},{"key":"2025082700475145000_16.9.e255144.13","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1016\/j.ekir.2021.09.008","article-title":"COVID-19 vaccination and glomerulonephritis","volume":"6","author":"Klomjit","year":"2021","journal-title":"Kidney Int Rep"},{"key":"2025082700475145000_16.9.e255144.14","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-244638","article-title":"Nephrotic syndrome with minimal change disease after the Pfizer-biontech COVID-19 vaccine: two cases","volume":"15","author":"Hartley","year":"2022","journal-title":"BMJ Case Rep"},{"key":"2025082700475145000_16.9.e255144.15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5414\/CNCS110924","article-title":"Minimal change disease and COVID-19 vaccination: four cases and review of literature","volume":"10","author":"Chandra","year":"2022","journal-title":"Clin Nephrol Case Stud"},{"key":"2025082700475145000_16.9.e255144.16","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1093\/ckj\/sfab123","article-title":"Minimal change disease following vaccination with coronavac","volume":"14","author":"Dirim","year":"2021","journal-title":"Clin Kidney J"},{"key":"2025082700475145000_16.9.e255144.17","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1093\/ckj\/sfab155","article-title":"Nephrotic syndrome and acute kidney injury following coronavac anti-SARS-CoV-2 vaccine","volume":"14","author":"Unver","year":"2021","journal-title":"Clin Kidney J"},{"key":"2025082700475145000_16.9.e255144.18","doi-asserted-by":"crossref","unstructured":"Hanna J , Ingram A , Shao T . Minimal change disease after first dose of Pfizer-biontech COVID-19 vaccine: a case report and review of minimal change disease related to COVID-19 vaccine. Can J Kidney Health Dis 2021;8. doi:10.1177\/20543581211058271","DOI":"10.1177\/20543581211058271"},{"key":"2025082700475145000_16.9.e255144.19","doi-asserted-by":"crossref","DOI":"10.3390\/medicina58010037","article-title":"De Novo minimal change disease following vaccination with the Pfizer\/biontech SARS-CoV-2 vaccine in a living kidney donor","volume":"58","author":"Marinaki","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"2025082700475145000_16.9.e255144.20","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1093\/ckj\/sfab156","article-title":"Minimal change disease soon after Pfizer-biontech COVID-19 vaccination","volume":"14","author":"Kobayashi","year":"2021","journal-title":"Clin Kidney J"},{"key":"2025082700475145000_16.9.e255144.21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/nep.13995","article-title":"Report of two cases of minimal change disease following vaccination for COVID -19","volume":"27","author":"Baskaran","year":"2022","journal-title":"Nephrology (Carlton)"},{"key":"2025082700475145000_16.9.e255144.22","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.5003","article-title":"Minimal change nephrotic syndrome four days after the administration of Pfizer-biontech COVID-19 vaccine-a new side effect or coincidence","volume":"9","author":"Abdulgayoom","year":"2021","journal-title":"Clin Case Rep"},{"key":"2025082700475145000_16.9.e255144.23","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/j.ajkd.2021.06.008","article-title":"Minimal change disease with severe acute kidney injury following the oxford-astrazeneca COVID-19 vaccine: a case report","volume":"78","author":"Leclerc","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"2025082700475145000_16.9.e255144.24","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/ckj\/sfab153","article-title":"Adult-onset nephrotic syndrome following coronavirus disease vaccination","volume":"15","author":"Biradar","year":"2022","journal-title":"Clin Kidney J"},{"key":"2025082700475145000_16.9.e255144.25","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/j.ekir.2021.06.024","article-title":"Nephrotic syndrome following Chadox1 nCoV-19 vaccine against SARSCoV-2","volume":"6","author":"Anupama","year":"2021","journal-title":"Kidney Int Rep"},{"key":"2025082700475145000_16.9.e255144.26","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s13730-021-00673-z","article-title":"A young adult with nephrotic syndrome following COVID-19 vaccination","volume":"11","author":"Nagai","year":"2022","journal-title":"CEN Case Rep"},{"key":"2025082700475145000_16.9.e255144.27","first-page":"662","article-title":"Nephrotic syndrome after vaccination against COVID-19: three new cases from Germany","volume":"118","author":"Dormann","year":"2021","journal-title":"Dtsch Arztebl Int"},{"key":"2025082700475145000_16.9.e255144.28","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/ckj\/sfab234","article-title":"Minimal change disease with thrombotic microangiopathy following the Pfizer-biontech COVID-19 vaccine","volume":"15","author":"Tanaka","year":"2022","journal-title":"Clin Kidney J"},{"key":"2025082700475145000_16.9.e255144.29","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s13730-022-00702-5","article-title":"A de novo case of minimal change disease following the first dose of the moderna mRNA-1273 SARS-CoV-2 vaccine without relapse after the second dose","volume":"11","author":"Mochizuki","year":"2022","journal-title":"CEN Case Rep"},{"key":"2025082700475145000_16.9.e255144.30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000521981","article-title":"De Novo minimal change disease in an adolescent after Pfizer-biontech COVID-19 vaccination: a case report","volume":"12","author":"Pella","year":"2022","journal-title":"Case Rep Nephrol Dial"},{"key":"2025082700475145000_16.9.e255144.31","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-009-1214-x"},{"key":"2025082700475145000_16.9.e255144.32","doi-asserted-by":"publisher","DOI":"10.1042\/CS20040095"},{"key":"2025082700475145000_16.9.e255144.33","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.kint.2021.09.002","article-title":"COVID-19 vaccination followed by activation of glomerular diseases: does association equal causation?","volume":"100","author":"Li","year":"2021","journal-title":"Kidney Int"},{"key":"2025082700475145000_16.9.e255144.34","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0140-6736(21)00501-8","article-title":"Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals","volume":"397","author":"Manisty","year":"2021","journal-title":"Lancet"},{"key":"2025082700475145000_16.9.e255144.35","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.03.019"},{"key":"2025082700475145000_16.9.e255144.36","first-page":"55","article-title":"Correlation between idiopathic nephrotic syndrome and atopy in children","volume":"12","author":"Berghea","year":"2017","journal-title":"Maedica (Bucur)"},{"key":"2025082700475145000_16.9.e255144.37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2007.00154.x"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2023-255144","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T07:48:01Z","timestamp":1756280881000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2023-255144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":37,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9,15]]},"published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1136\/bcr-2023-255144"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2023-255144","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9]]}}}